GSK chief shrugs off concerns over leadership as she outlines plans
GSK chief executive Emma Walmsley has pushed back against concerns over her leadership, saying she is a “change agent” committed to transforming the UK drugmaker after the spin-off of its consumer health division. Under pressure from US hedge fund Elliott Management, Walmsley set out her vision for the group, targeting £33bn in sales by 2031 and…
Read more